You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
STTR Phase I: 24x7 mobile wireless monitoring of patient's vitals to proactively manage disease recovery
SBC: Argosy Omnimedia, Inc. Topic: SHThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is found in the proposed technology development that facilitates direct, ubiquitous acquisition of key biomedical data, with little or no human intervention or introduction of errors, has the potential to reduce the costs of healthcare and to revolutionize healthcare delivery throughout our so ...
STTR Phase I 2014 National Science Foundation -
STTR Phase I: Ferrofluidic enclosures for enhanced control of thermal and magnetic fields in spin-stabilized atomic micro-devices
SBC: COMMET LLC Topic: EWThe broader impact/commercial potential of this project is determined by new consumer products and new industries which would flourish on portable and reliable atomic clocks, gyroscopes, and magnetometers when they become available. Proposed compact thermal and magnetic enclosure reduces the most bulky part of such devices and provides an avenue for further miniaturization. A chip-scale atomic clo ...
STTR Phase I 2014 National Science Foundation -
Development of Peptide Antibiotic Nucleic Acids
SBC: NUBAD LLC Topic: NIAIDDESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of a novel highly effective influenza vaccine
SBC: FLUGEN INC Topic: NIAIDDESCRIPTION provided by applicant Seasonal influenza flu virus an NIAID category C priority pathogen causes widespread infection resulting in at least million cases of severe illness and deaths worldwide Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or death from influenza Newly emerging strains can result ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Rabbit InMAD Discovery of Novel Biomarkers for POC Tuberculosis Diagnostic Assay
SBC: Immuno-mycologics, Inc. Topic: NIAIDDESCRIPTION provided by applicant Tuberculosis TB is a chronic infectious disease that infects approximately one third of the worldandapos s population Eighty five percent of the estimated million new cases of TB in occurred in resource limited countries located in Asia and Africa In there were million deaths from TB among HIV negative patients and additional TB d ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Light Weight Optics For High Power Directed Energy Applications
SBC: BRIMROSE TECHNOLOGY CORP Topic: MDA13T009The objective of this proposal is to demonstrate the feasibility of producing light weight and thermally manageable integrated optical systems suitable for airborne and space high power directed energy applications. This project will focus on improving two of the most important parts of a high energy mirror design, the reflective mirror surface, and the multifunctional substrate. Brimrose, in coll ...
STTR Phase I 2014 Department of DefenseMissile Defense Agency -
STTR Phase I: Efficient Mid-Infrared Interband Cascade Lasers
SBC: Applied Quantum Enovation LLC Topic: EIThis Small Business Technology Transfer (STTR) Phase I project will develop efficient interband cascade lasers based on innovative hybrid waveguides using dielectric and metal layers. The hybrid-waveguide interband cascade lasers will be much less demanding in the growth of device structures and will have efficient continuous wave operation in a wide range of wavelengths, as well as more capabilit ...
STTR Phase I 2014 National Science Foundation -
STTR Phase I: Sensulin AVT: A 24-hour glucose-responsive insulin
SBC: Sensulin, LLC Topic: BCThis Small Business Technology Transfer (STTR) Phase I project?s primary objective is to develop a glucose-responsive platform for 24-hour delivery of insulin for type 1 and type 2 diabetes, which will cover the patient?s entire daily dose in a single administration. The company?s drug delivery technology platform is designed to passively deliver the right amount of insulin at the right time. Succ ...
STTR Phase I 2014 National Science Foundation -
Development of VPL Vaccine for RSV
SBC: SIGMOVIR BIOSYSTEMS, INC. Topic: NIAIDProject Summary Human respiratory syncytial virus (RSV) is recognized as the single most important viral cause of acute respiratory disease in infants and young children worldwide. Elderly populations and immunocompromised individuals are also at significant risk for serious RSV disease. Despite this very substantial disease burden imposed by RSV worldwide, there are no vaccines available. Severa ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics
SBC: PPI PHARMACEUTICALS, LLC Topic: NCIDESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health